Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingyang Wang
Observed name:
Q. Wang
Institutions:
China-Japan Friendship Hospital,
Chengdu Second People's Hospital
Observed institutions:
China-Japan Friendship Hospital,
Chengdu Second People's Hospital,
Henan Cancer Hospital
ORCID:
0000-0002-1640-489X
Observed ORCID:
0000-0002-1640-489X
OpenAlex ID:
A5042537297
OA04.03 A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
2019
·
C. Zhou
, G. Chen
, et al.
·
Journal of Thoracic Oncology
·
31
PDF
TRIM21-NUP98 Interface Accommodates Structurally Diverse Molecular Glue Degraders
2025
·
Yalong Cheng
, Longzhi Cao
, et al.
·
ACS Chemical Biology
·
19
PDF
Automated recognition and segmentation of lung cancer cytological images based on deep learning
2025
·
Qingyang Wang
, Yazhi Luo
, et al.
·
PLoS ONE
·
4
P3.03-006 Efficiency of Anlotinib as 3rd Line Treatment in Patients with Different EGFR Gene Status, an Exploratory Subgroup Analysis of ALTER0303 Trial
2017
·
B. Han
, K. Li
, et al.
·
Journal of Thoracic Oncology
·
4
LBA4 The efficacy and safety of TQ-B2450 alone/with anlotinib in previously treated advanced non-small cell lung cancer (NSCLC): A multicenter, randomized, double-blind, placebo-controlled clinical trial
2021
·
B. Han
, K. Li
, et al.
·
Annals of Oncology
·
3
135P Camrelizumab plus chemotherapy as first-line therapy for NSCLC: A pooled analysis of two randomized phase III trials with extended follow-up
2022
·
C. Zhou
, G. Chen
, et al.
·
Immuno-Oncology Technology
·
2
PDF
1791P Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202)
2020
·
Y. Cheng
, Q. Wang
, et al.
·
Annals of Oncology
·
2
Antidepressants simulate enriched environment enhance platinum chemosensitivity of small cell lung cancer
2017
·
Y. Wu
, Q. Wang
, et al.
·
Annals of Oncology
497O_PR Depression induces poor prognosis via the downregulation of brain derived neurotrophic factor in advanced small cell lung cancer
2016
·
Y. Wu
, H. Tang
, et al.
·
Annals of Oncology
449PD Relative abundance of EGFR mutations predict tumor metastasis and EGFR-TKIs prognosis in patients with nonsmall cell lung cancer
2016
·
H. Zhen
, Q. Wang
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
10
Citation count:
65
H-index:
4
I10-index:
2
Year
Topic
Type